Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · IEX Real-Time Price · USD
4.26 -0.08 (-1.84%)
Oct 25, 2021 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is November - October.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0.25 | 1.11 | 0.36 | 0.3 | 9.26 | 3.67 | 0.39 | 0.94 | 1 |
| Revenue Growth | - | -77.53% | 206.90% | 20.83% | -96.76% | 152.36% | 843.12% | -58.63% | -6.30% | - |
| Cost of Revenue | 0 | 0.17 | 0.77 | 0.1 | 0.22 | 3.65 | 1.99 | 0.32 | 0 | 0.03 |
| Gross Profit | 0 | 0.08 | 0.34 | 0.26 | 0.08 | 5.61 | 1.68 | 0.07 | 0.94 | 0.97 |
| Selling, General & Admin | 5.6 | 5.66 | 6.91 | 4.41 | 2.71 | 5.51 | 6.41 | 7.99 | 2.86 | 2.87 |
| Research & Development | 4.38 | 5.47 | 6.81 | 1.6 | 1.56 | 0.71 | 0 | 0 | 2.21 | 3.12 |
| Other Operating Expenses | 0.15 | 0.84 | 0.91 | 0.33 | 0.33 | 0.33 | 0.31 | 0 | 0 | 0 |
| Operating Expenses | 10.13 | 11.97 | 14.63 | 6.33 | 4.59 | 6.55 | 6.72 | 7.99 | 5.07 | 6 |
| Operating Income | -10.13 | -11.89 | -14.29 | -6.08 | -4.51 | -0.94 | -5.04 | -7.92 | -4.13 | -5.03 |
| Interest Expense / Income | 0 | 0 | 0 | 0.5 | 0.52 | 0.45 | 1.26 | 1.11 | 0.01 | 0 |
| Other Expense / Income | -0.11 | -0.24 | -0.29 | -1.57 | -0.01 | -0.02 | 3.3 | 1.05 | 0.11 | 1.75 |
| Pretax Income | -10.02 | -11.65 | -14 | -5.01 | -5.02 | -1.38 | -9.61 | -10.08 | -4.25 | -6.78 |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.6 |
| Net Income | -10.02 | -11.65 | -14 | -5.01 | -5.02 | -1.38 | -9.61 | -10.08 | -4.25 | -7.38 |
| Preferred Dividends | 0 | 0 | 0 | 2.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Common | -10.02 | -11.65 | -14 | -7.02 | -5.02 | -1.38 | -9.61 | -10.08 | -4.25 | -7.38 |
| Shares Outstanding (Basic) | 22 | 20 | 18 | 12 | 9 | 9 | 9 | 8 | 7 | 7 |
| Shares Outstanding (Diluted) | 22 | 20 | 18 | 12 | 9 | 9 | 9 | 8 | 7 | 7 |
| Shares Change | 12.33% | 12.29% | 44.49% | 39.57% | -0.24% | 0.57% | 10.74% | 8.24% | 8.88% | - |
| EPS (Basic) | -0.45 | -0.59 | -0.79 | -0.58 | -0.57 | -0.16 | -1.10 | -1.25 | -0.50 | -1.00 |
| EPS (Diluted) | -0.45 | -0.59 | -0.79 | -0.58 | -0.57 | -0.16 | -1.10 | -1.25 | -0.50 | -1.00 |
| Free Cash Flow Per Share | -0.28 | -0.25 | -0.24 | -0.31 | -0.40 | 0.15 | -0.27 | -0.41 | -0.43 | -0.11 |
| Gross Margin | - | 33.50% | 30.93% | 71.16% | 27.53% | 60.58% | 45.79% | 18.57% | 100.00% | 96.60% |
| Operating Margin | - | -4756.00% | -1284.41% | -1676.02% | -1503.00% | -10.21% | -137.54% | -2036.17% | -439.84% | -501.23% |
| Profit Margin | - | -4658.82% | -1258.07% | -1381.79% | -1672.14% | -14.90% | -261.94% | -2592.28% | -452.42% | -735.46% |
| Free Cash Flow Margin | - | -1966.75% | -387.58% | -1043.28% | -1176.07% | 14.14% | -65.06% | -819.54% | -334.12% | -72.27% |
| Effective Tax Rate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -8.85% |
| EBITDA | -9.93 | -11.6 | -13.98 | -4.47 | -4.46 | -0.91 | -8.34 | -8.97 | -4.25 | -6.78 |
| EBITDA Margin | - | -4639.80% | -1256.41% | -1231.81% | -1487.72% | -9.88% | -227.49% | -2306.95% | -451.61% | -675.65% |
| EBIT | -10.02 | -11.65 | -14 | -4.51 | -4.5 | -0.93 | -8.34 | -8.97 | -4.25 | -6.78 |
| EBIT Margin | - | -4658.82% | -1258.07% | -1243.73% | -1498.83% | -10.02% | -227.49% | -2306.95% | -451.61% | -675.65% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).